Trial intelligence / Profile preview

Impact of Grapefruit Juice on Clopidogrel Response

NCT00817999Phase 4Completed

Sponsor
Creighton University
Start
Nov 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of clopidogrel in thrombosis (2 arms), sponsored by Creighton University. Primary endpoint: Percentage of Platelet Aggregation Inhibition at 6 hours. Started Nov 2008; status: completed.

02

Drugs

clopidogrel
03

Conditions

thrombosis

Beyond the preview

Go deeper on NCT00817999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00817999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call